Nutra Pharma Corp (NPHC) Financial Statements (2024 and earlier)

Company Profile

Business Address 12538 W. ATLANTIC BLVD.
CORAL SPRINGS, FL 33071
State of Incorp. CA
Fiscal Year End December 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 1079145502
Cash and cash equivalents 1079145502
Receivables475352474137
Inventory, net of allowances, customer advances and progress billings42643133344
Inventory42643133344
Prepaid expense9188861928055
Other undisclosed current assets 31528427325515878
Total current assets:505496534572364176
Noncurrent Assets
Inventory, Noncurrent929899999979
Operating lease, right-of-use asset597594112137148
Property, plant and equipment929745434223
Other undisclosed noncurrent assets999999
Total noncurrent assets:252280246263286259
TOTAL ASSETS:757776780835650435
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,4813,4382,5782,9812,8211,332
Interest and dividends payable537503    
Employee-related liabilities1,3551,3121,0541,5551,507 
Accounts payable666737672612538532
Accrued liabilities922887851814776800
Deferred revenue80     
Debt   7,6007,7778,4408,473
Derivative instruments and hedges, liabilities5,3866,11110,53712,60627,05029,691
Due to related parties110141200181192197
Other undisclosed current liabilities7,6836,5022252292231,704
Total current liabilities:16,74016,19221,14023,77538,72641,397
Noncurrent Liabilities
Long-term debt and lease obligation1992985176801,1681,892
Long-term debt, excluding current maturities1992985176601,1281,833
Liabilities, other than long-term debt 1560    
Due to related parties 1560    
Operating lease, liability    204059
Other undisclosed noncurrent liabilities    (20)(40)(59)
Total noncurrent liabilities:2143585176801,1681,892
Total liabilities:16,95416,55021,65824,45639,89443,289
Equity
Equity, attributable to parent, including:(16,197)(15,774)(20,878)(23,621)(39,244)(42,854)
Preferred stock1212 333
Common stock7,5867,3647,3317,3087,2687,225
Additional paid in capital53,56653,56653,50852,96652,81752,567
Deferred compensation equity  (10)(21)(84)(32) 
Accumulated deficit(77,361)(76,716)(81,729)(83,898)(99,331)(102,650)
Other undisclosed equity, attributable to parent  10338432 
Total equity:(16,197)(15,774)(20,878)(23,621)(39,244)(42,854)
TOTAL LIABILITIES AND EQUITY:757776780835650435

Income Statement (P&L) ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Revenues902226193022
Revenue from related parties      
Cost of revenue
(Cost of Goods and Services Sold)
(61)(14)(65)(10)(9)(6)
Other undisclosed gross profit      
Gross profit:308(39)102116
Operating expenses(371)(316)(457)(522)(460)(558)
Operating loss:(341)(308)(496)(512)(439)(541)
Nonoperating income (expense)(305)5,3222,66515,9463,801(33,475)
Interest and debt expense(4)(4)(4)(5)(4)(5)
Income (loss) from continuing operations before equity method investments, income taxes:(650)5,0092,16515,4293,358(34,021)
Other undisclosed income from continuing operations before income taxes444545
Income (loss) from continuing operations:(646)5,0132,16915,4333,362(34,016)
Income (loss) before gain (loss) on sale of properties:(646)5,0132,16915,4333,362(34,016)
Net income (loss) available to common stockholders, basic:(646)5,0132,16915,4333,362(34,016)
Interest on convertible debt 83 9158 
Net income (loss) available to common stockholders, diluted:(646)5,0962,16915,5253,421(34,016)

Comprehensive Income ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Net income (loss):(646)5,0132,16915,4333,362(34,016)
Comprehensive income (loss), net of tax, attributable to parent:(646)5,0132,16915,4333,362(34,016)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: